COR-3

N/A

Report date: 2025/01/26 19:17:46

Base Information

Drug NameCOR-3
Drug Alias Nameanti-GPVI antibody (Advancecor)anti-glycoprotein VI antibody (Advancecor)COR-3
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionPlatelet membrane glycoprotein VI inhibitorsCD133 modulators
TargetsCD133Platelet membrane glycoprotein VI
Therapy Area/IndicationsAtherosclerosisCoronary RestenosisAcute Coronary Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorimmun Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesAdvancecor Gmbh
Inactive CompaniesCorimmun GmbhJanssen-Cilag Ltd
Active IndicationsCoronary RestenosisAcute Coronary Syndrome
Inactive IndicationsAtherosclerosisCardiovascular DiseasesStroke

Other Information

ATC CodeN/A
Related LinksN/A